-
Bionano Genomics closes $10 million public offering with warrants
-
Bionano Genomics prices $10 million public offering at $2 per share
-
CMS sets $1,263.53 payment rate for Bionano optical genome mapping code
-
BTIG Reiterates Neutral Rating on Bionano Genomics (BNGO)
-
Bionano Genomics (BNGO) PT Raised to $11 at H.C. Wainwright
-
BioNano Genomics, Inc. (BNGO) Sets January 24 as Effective Date of 1:60 Reverse Share Split
-
BioNano Genomics, Inc. (BNGO) Reports Preliminary Fourth Quarter and Full-Year 2024 Results
-
BioNano Genomics, Inc. (BNGO) Files for 50.56M Share Offering by Selling Stockholders
-
BioNano Genomics, Inc. (BNGO) Prices 39.68M Share Offering at $0.252/sh
-
BioNano Genomics (BNGO) Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway
-
BTIG Reiterates Neutral Rating on Bionano Genomics (BNGO)
-
Ladenburg Thalmann Downgrades Bionano Genomics (BNGO) to Neutral
-
BioNano Genomics, Inc. (BNGO) Prices 9.88M Share Offering at $0.304/sh
-
BioNano Genomics (BNGO) Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma
-
BioNano Genomics, Inc. (BNGO) Announces Preliminary 3Q 2024 Revenues and Cash
-
BTIG Downgrades Bionano Genomics (BNGO) to Neutral
-
BTIG Reiterates Buy Rating on Bionano Genomics (BNGO)
-
BioNano Genomics, Inc. (BNGO) Files for 35.02M Share Offering by Selling Stockholders
-
BioNano Genomics, Inc. (BNGO) Announces up to $30 Million Registered Direct Offering of Common Stock, Warrants
-
BioNano Genomics, Inc. (BNGO) Enters Marketing Agreement with Revvity (RVTY)

